PMID- 14764592 OWN - NLM STAT- MEDLINE DCOM- 20040722 LR - 20210206 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 279 IP - 16 DP - 2004 Apr 16 TI - Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. PG - 16326-31 AB - The Ah receptor nuclear translocator (ARNT) is the dimeric partner of hypoxia-inducible factors and thus plays a pivotal role in cellular adaptation to low oxygen environments. ARNT is also a dimeric partner for the Ah receptor (AHR), and this complex is essential in regulating the adaptive metabolic response to polycyclic aromatic hydrocarbons. Because of the essential role of ARNT in hypoxia-driven developmental events, it has been difficult to study the physiological significance of AHR.ARNT heterodimers in vivo. To address this issue, we developed a hypomorphic Arnt allele that displayed normal development and allowed the examination of the role of ARNT in AHR biology. In this regard, the AHR is also known to mediate two additional biological processes: the toxicological response to compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) and the developmental closure of a fetal vascular structure known as the ductus venosus. Although the mechanism of the adaptive pathway has been well described, the mechanism of AHR-mediated signal transduction in the toxic and developmental pathways is not well understood. Liver perfusion studies demonstrated that ARNT hypomorphs have a patent ductus venosus, identical to that observed in the Ahr null mice. Parallel dioxin toxicity studies demonstrated that the ARNT hypomorphs exhibited resistance to the end points of dioxin exposure. Moreover, we observed that toxicity could be segregated from the classical adaptive responses such as P4501A induction. Taken in sum, these experiments demonstrate that ARNT is an essential component of AHR developmental signaling and shed light on the mechanism of dioxin toxicity. FAU - Walisser, Jacqueline A AU - Walisser JA AD - McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA. FAU - Bunger, Maureen K AU - Bunger MK FAU - Glover, Edward AU - Glover E FAU - Harstad, Eric B AU - Harstad EB FAU - Bradfield, Christopher A AU - Bradfield CA LA - eng GR - P01 CA022484/CA/NCI NIH HHS/United States GR - CA014520/CA/NCI NIH HHS/United States GR - R01 ES006883/ES/NIEHS NIH HHS/United States GR - CA022484/CA/NCI NIH HHS/United States GR - ES006881/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20040205 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Arnt protein, mouse) RN - 0 (DNA-Binding Proteins) RN - 0 (Dioxins) RN - 0 (Receptors, Aryl Hydrocarbon) RN - 0 (Transcription Factors) RN - 138391-32-9 (Aryl Hydrocarbon Receptor Nuclear Translocator) SB - IM MH - Alleles MH - Animals MH - Aryl Hydrocarbon Receptor Nuclear Translocator MH - *DNA-Binding Proteins MH - Dioxins/*toxicity MH - Drug Resistance/*genetics MH - Ductus Arteriosus, Patent/*genetics/metabolism MH - Mice MH - Receptors, Aryl Hydrocarbon/*genetics/metabolism MH - Signal Transduction/genetics MH - Transcription Factors/*genetics/metabolism EDAT- 2004/02/07 05:00 MHDA- 2004/07/23 05:00 CRDT- 2004/02/07 05:00 PHST- 2004/02/07 05:00 [pubmed] PHST- 2004/07/23 05:00 [medline] PHST- 2004/02/07 05:00 [entrez] AID - S0021-9258(20)88357-4 [pii] AID - 10.1074/jbc.M400784200 [doi] PST - ppublish SO - J Biol Chem. 2004 Apr 16;279(16):16326-31. doi: 10.1074/jbc.M400784200. Epub 2004 Feb 5.